Search
for
Sort by
Research 151–180 of 1000+
- Safety and efficacy of ALRV5XR in women with androgenetic alopecia or telogen effluvium: A randomised, double-blinded, placebo-controlled clinical trial
- Ultra-low dose estradiol and dydrogesterone for the treatment of menopausal symptoms in a pooled, multi-ethnic population
- Therapeutic Potential of Gynostemma pentaphyllum Extract for Hair Health Enhancement: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial
- Safety and efficacy of ALRV5XR in men with androgenetic alopecia: A randomised, double-blinded, placebo-controlled clinical trial
- Effectiveness and safety of Baricitinib in alopecia areata: a prospective cohort study
- Biologics and Small Molecules for Inflammatory Nail Disorders: A Narrative Review
- Long-Term Effectiveness and Safety of Dutasteride versus Finasteride in Patients with Male Androgenic Alopecia in South Korea: A Multicentre Chart Review Study
- Overview of Caffeine Effects on Human Health and Emerging Delivery Strategies
- Efficacy and safety of topical 3% minoxidil for facial hair enhancement in transmen: a randomized, double-blind, placebo-controlled trial
- Digoxin-induced anemia among patients with atrial fibrillation and heart failure: clinical data analysis and drug-gene interaction network
- Spectrum and signals of medication-associated cognitive disorder: a comprehensive disproportionality analysis with cross-database validation
- Central nervous system demyelination associated with tofacitinib use in alopecia areata: A case report and literature review
- Hormone replacement therapy and COVID-19 outcomes in solid organ transplant recipients compared with the general population
- (024) Monitored Hormone Therapy in Women 70 Years and Older: Aging Does Not Mean Sexual Retirement
- Pramipexole
- This Week in JAMA
- PCSK9: From Nature’s Loss to Patient’s Gain
- GLP-1 Receptor Agonists: Beyond Their Pancreatic Effects
- Dose-Dependent Increases in Carotid Intima-Media Thickness Associated with Oral Minoxidil but Not Dutasteride in Healthy Young Males: A Randomized Controlled Pharmacological Trial
- Abstracts Pt.30
- Tumor Angiogenesis and Anti-angiogenic Therapy
- Overview of Caffeine Effects on Human Health and Emerging Delivery Strategies
- Teriflunomide: A Once-daily Oral Medication for the Treatment of Relapsing Forms of Multiple Sclerosis
- Consequences of Anabolic-Androgenic Steroid Abuse in Males; Sexual and Reproductive Perspective
- 277 An open label pilot clinical trial of the JAK inhibitor tofacitinib for alopecia areata
- 608 A clinical study to test the efficacy of VB1953 in clindamycin non-responder acne patients with antibiotic-resistant P. acnes
- Hormonal Influences on Women's Health and Athletic Performance: Insights into the Menstrual Cycle, Menopause, Contraception, and Anabolic Steroids
- Efficacy and safety of the oral Janus kinase inhibitor baricitinib in the treatment of adults with alopecia areata: Phase 2 results from a randomized controlled study
- Clinical evidence for JAK inhibition in alopecia areata: A comprehensive review
- Baricitinib Provides Significant Hair Regrowth In Adolescents With Severe Alopecia Areata: 52-Week Efficacy and Safety Results From A Phase 3 Randomized, Controlled Trial